DIAMPA LXR 25/5/1000MG TAB NEW

DIAMPA LXR is a combination tablet containing empagliflozin, linagliptin, and metformin HCl designed to help manage type 2 diabetes. This triple-action formulation works through multiple mechanisms: empagliflozin helps the kidneys remove excess glucose, linagliptin slows sugar breakdown, and metformin reduces liver glucose production. Suitable for patients requiring comprehensive glycemic control, DIAMPA LXR offers convenient once-daily dosing in a single tablet format, reducing pill burden while supporting better blood sugar management.